MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Chinese medicine pattern diagnostic criteria in clinical and epidemiological studies of Parkinson’s disease: a systematic review

    CP. Ho, S. Yuen, C. Chan, M. Li, KK. Chua (Hong Kong, Hong Kong)

  • Chinese proprietary medicine as adjunct treatment for Parkinson’s disease: a systematic review and meta-analysis

    S. Yuen, KK. Chua, SC. Chen, CP. Ho, C. Chan, M. Li (Hong Kong, Hong Kong)

  • Cholinergic deficits in Parkinson Disease

    R. Miller, D. Dhavale, J. O’Shea, E. Franklin, N. Cairns, R. Perrin, M. Campbell, J. Perlmutter, P. Kotzbauer (St. Louis, USA)

  • Cholinergic subtyping in Parkinson disease: differential 2-year interval changes

    N. Bohnen, S. Roytman, T. Brown, K. Frey, P. Scott, R. Koeppe, R. Albin, P. Kanel (Ann Arbor, USA)

  • Cholinergic topography and clinical profile of early Parkinson’s patients with GBA mutations

    S. Slingerland, S. Vander Zee, G. Carli, A. Slomp, J. Boertien, T. van Laar (Groningen, Netherlands)

  • Chorea as a clinical manifestation in adult-onset of metachromatic leukodystrophy

    NT. Dragašević Mišković, A. Milovanović, M. Branković, I. Novaković, I. Petrović, A. Tomić Pešić, M. Svetel, VS. Kostić (Belgrade, Serbia)

  • Chorea following SARS-CoV-2 infection and vaccination: a systematic review

    R. Bilavu, M. Simu, E. Rosca (Timișoara, Romania)

  • Chorea improvements over time with once-daily valbenazine treatment in adults with Huntington disease

    E. Furr Stimming, E. Kayson, J. Goldstein, H. Zhang, O. Klepitskaya, G. Liang, D. Haubenberger (Houston, USA)

  • Choroidal changes in Parkinson’s disease: A longitudinal follow up study

    P. Mailankody, R. Battu, PM. Pm, T. K, N. Kamble, R. Yadav, P. Pal (Bangalore, India)

  • Chromosomal Microarray Analysis for genetic evaluation of dystonia

    A. Saini, R. Rajan, R. Mewara, B. Verma, N. Gupta, D. Radhakrishnan, E. A, A. Gupta, V. Vy, M. Singh, R. Bhatia, A. Srivastava, M. Srivastava (New Delhi, India)

  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Comorbid Normal Pressure Hydrocephalus with Parkinson’s disease: a call for clinical awareness
  • Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley